Day Three – 30th November, 2012

Speaker Panel

Industry

Founder

Synthes, Turkey

Secretary General

European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)

Senior Director Global Health Economics & Reimbursement, Spine & Biologics

Medtronic

Payers

General Director

Private Hospitals and Healthcare Organisations Association (OHSAD), Turkey

Director

State Health Care Accreditation Agency, Lithuania

Scientific Coordinator

Mexican Health Foundation, Mexico

President,

ISPOR

Chair of Health Care Policymakers & Payers Committee,

ISPOR Latin America Consortium,

Coordinator of the Oncology Unit,

UNIMED, Brazil

Advisor for EU Affairs

Croatian Agency for Medicinal Products and Medical Devices

Solution Provider

Vice President - Asia

Boston Healthcare

Medical Device Market Access Strategies in Emerging Markets

Meeting the needs of payers to achieve emerging market access in the MedTech Arena

Health technology device companies are increasingly turning to emerging markets to accelerate growth.

Budget cuts, ageing populations and an emerging middle class have resulted in opportunities and challenges for medical device manufacturers entering emerging markets.

The primary risks and challenges vary from market to market and present a complex playing field for medical device companies.

Companies that lack a well-planned emerging market chain strategy are at risk of ending up with limited growth and profitability.

Manufacturers with extensive emerging market experience will present case-study examples of successful market-penetration strategies and explore the real potential for further growth.

Request Agenda Register Online